| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $261.7M | +4.0% |
| Cost of Revenue | $51.4M | +7.2% |
| Gross Profit | $210.3M | +3.2% |
| R&D Expense | $57.7M | +4.5% |
| SG&A Expense | $25.3M | +5.9% |
| Operating Income | $44.0M | +13.8% |
| Pre-tax Income | $58.1M | +32.7% |
| Income Tax | $8.0M | +108.1% |
| Net Income | $50.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $100.4M | +61.8% |
| Accounts Receivable | $76.7M | +3.2% |
| Inventory | $22.0M | -6.4% |
| Current Assets | $307.3M | +13.0% |
| Total Assets | $432.8M | +11.0% |
| Current Liabilities | $123.6M | +11.3% |
| Total Liabilities | $201.0M | +10.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $90.5M | +103.3% |
| Capital Expenditures | $12.3M | +12.6% |
| Investing Cash Flow | -$48.4M | -455.3% |
| Financing Cash Flow | -$44.3M | -53.4% |
| Free Cash Flow | $78.2M | +132.7% |
| +25.4% |
| EPS (Basic) | $0.68 | +25.9% |
| EPS (Diluted) | $0.67 | +26.4% |
| Stockholders' Equity |
| $231.8M |
| +11.5% |